Immune classification of soft tissue sarcoma and its association with molecular characteristics, and clinical outcome

被引：2
|
作者：
Petitprez, F. [1 ]
de Reynies, A. [2 ]
Chen, T. W-W. [3 ]
Sun, C-M. [1 ]
Lacroix, L. [1 ]
Adam, J. [4 ]
Toulmonde, M. [5 ]
Italiano, A. [6 ]
Sautes-Fridman, C. [1 ]
Fridman, W-H. [7 ]
机构：
[1] Ctr Rech Cordeliers, Equipe Canc & Immun Antitumorale, Paris, France
[2] Ligue Natl Canc, Programme Cartes Ident Tumeurs, Paris, France
[3] Natl Taiwan Univ Hosp, Taipei, Taiwan
[4] Inst Gustave Roussy, Villejuif, France
[5] Inst Bergonie, Bordeaux, France
[6] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France
[7] Ctr Rech Cordeliers, Canc, Immunol, Immunopathol, Paris, France
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
10.1093/annonc/mdy319.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
112O
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [31] Molecular landscape of canine soft tissue sarcoma
    Das, Sunetra
    Idate, Rupa
    Regan, Daniel P.
    Lana, Susan E.
    Duval, Dawn L.
    FASEB JOURNAL, 2022, 36
  • [32] Molecular target therapy for soft tissue sarcoma
    Naito, Yoichi
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients
    Adrian Stelzl
    Faisal Aziz
    Jakob M. Riedl
    Florian Posch
    Maria A. Smolle
    Tatjana Stojakovic
    Angelika Terbuch
    Martin Pichler
    Marko Bergovec
    Andreas Leithner
    Bernadette Liegl-Atzwanger
    Michael Stotz
    Armin Gerger
    Harald Sourij
    Joanna Szkandera
    Scientific Reports, 10
  • [34] Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients
    Stelzl, Adrian
    Aziz, Faisal
    Riedl, Jakob M.
    Posch, Florian
    Smolle, Maria A.
    Stojakovic, Tatjana
    Terbuch, Angelika
    Pichler, Martin
    Bergovec, Marko
    Leithner, Andreas
    Liegl-Atzwanger, Bernadette
    Stotz, Michael
    Gerger, Armin
    Sourij, Harald
    Szkandera, Joanna
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [35] Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma
    Spunt, SL
    Hill, DA
    Motosue, AM
    Billups, CA
    Cain, AM
    Rao, BN
    Pratt, CB
    Merchant, TE
    Pappo, AS
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) : 3225 - 3235
  • [36] Outcome of primary soft tissue sarcoma of the knee and elbow
    Alektiar, KM
    McKee, AB
    Jacobs, JM
    McKee, BJ
    Healey, JH
    Brennan, MF
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (01): : 163 - 169
  • [37] Systemic therapy of soft tissue sarcoma: an improvement in outcome
    Judson, I
    ANNALS OF ONCOLOGY, 2004, 15 : 193 - 196
  • [38] OUTCOME AND PROGNOSIS IN RETROPERITONEAL SOFT-TISSUE SARCOMA
    CATTON, CN
    OSULLIVAN, B
    KOTWALL, C
    CUMMINGS, B
    HAO, Y
    FORNASIER, V
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (05): : 1005 - 1010
  • [39] OUTCOME AND PROGNOSIS IN RETROPERITONEAL SOFT-TISSUE SARCOMA
    CATTON, CN
    OSULLIVAN, B
    KOTWALL, C
    CUMMINGS, B
    HAO, Y
    FORNASIER, V
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 295 - 295
  • [40] Immune checkpoint inhibitor resistance in soft tissue sarcoma
    Eulo, Vanessa
    Van Tine, Brian A.
    CANCER DRUG RESISTANCE, 2022, 5 (02) : 328 - 338
12345